Results 181 to 190 of about 5,003,572 (301)

Monitoring Extended Half-Life Factor VIII and IX Concentrates: Performance in Routine Clotting-and Thrombin Generation Assays. [PDF]

Haemophilia
Stroobants AK, Göttgens EL, Henskens YMC, Jansen JH, Schols SEM, Rijpma SR.   +5 more
europepmc   +1 more source

Artificial Intelligence in Systemic Sclerosis: Clinical Applications, Challenges, and Future Directions

Arthritis Care &Research, EarlyView.
Systemic sclerosis (SSc) is a rare autoimmune disease defined by immune dysregulation, vasculopathy, and progressive fibrosis of the skin and internal organs. Despite advances in care, major complications such as interstitial lung disease (ILD) and myocardial involvement remain the leading causes of morbidity and mortality.
Cristiana Sieiro Santos, José Miguel Sequí‐Sabater, Diego Benavent   +2 more
wiley   +1 more source

Elevated Factor VIII in the Setting of Recurrent Ischemic Strokes. [PDF]

Cureus
Bakshi N, Kardouh MS, Wang C, Amal T.
europepmc   +1 more source

Artificial Intelligence–Based Online Symptom Assessment Tools for Systemic Lupus Erythematosus Diagnosis: Patient Perspectives

Arthritis Care &Research, EarlyView.
Objective The objective of this article is to identify perceptions of patients with systemic lupus erythematosus (SLE) regarding artificial intelligence (AI)–based online symptom assessment tools, and the potential of these tools to address diagnostic barriers.
Olivia A. Stein, Jennifer L. F. Lee, Evelyne Vinet, Arielle Mendel, Christian A. Pineau, Fares Kalache, Louis‐Pierre Grenier, Sasha Bernatsky   +7 more
wiley   +1 more source

Characterization of a factor VIII/immunoglobulin heavy chain μ double-knockout mouse model of hemophilia A for long-term exposure to factor VIII proteins. [PDF]

Res Pract Thromb Haemost
Monica L, Oleshko O, Aires L, Wuschko S, Füner J, Paul H, Schauerte P, Jespersen DS, Belyanskaya L, Tiede A, Werwitzke S.   +10 more
europepmc   +1 more source

Development of a novel hemophilia A mouse model to study emicizumab and factor VIII inhibitor risk. [PDF]

Blood Adv
Chou SC, Chang YT, Chen LF, Tsai CH, Cheng CY, Sun CP, Tao MH, Hong CL, Wu HL, Lin SW.   +9 more
europepmc   +1 more source

Caregiver Perspectives on the Burden of Disease and Treatment in Uncontrolled Gout

Arthritis Care &Research, EarlyView.
Objective Uncontrolled gout (UG) refers to persistently elevated serum urate (SU) levels >6 mg/dL and ongoing gout symptoms despite use of urate‐lowering therapy (ULT). The objective of this study was to evaluate the burden associated with informal caregiving for individuals with UG.
Angelo Gaffo, Bhavisha Desai, Abiola Oladapo, Nana Kragh, Rebekah Zincavage, Brad Padilla, Naomi Schlesinger   +6 more
wiley   +1 more source

Von Willebrand, factor VIII, and D-dimer levels as predictors of risk and clinical outcomes in acute myeloid leukemia. [PDF]

Clin Exp Med
El-Sayed HA, Sakr DH, Ebrahim MA, Alghandour R, Eid E, Denewer M, Saarsalu B, Othman M, Azzam H.   +8 more
europepmc   +1 more source

Factors Associated With Fibromyalgia Diagnosis Among People Meeting Criteria: Results From UK Biobank

Arthritis Care &Research, EarlyView.
Objective The diagnosis of fibromyalgia (FM) is challenging due to the absence of definitive biomarkers, numerous overlapping comorbidities, and its reliance on patient‐reported symptoms. Discrepancies between diagnostic criteria and clinical practice imply the possibility of diagnostic biases, complicating timely and accurate identification.
Sung‐A Kim, Gary J. Macfarlane, Marcus J. Beasley   +2 more
wiley   +1 more source

Multicentre Retrospective and Prospective Analysis of Data on Emicizumab and Factor VIII Prophylaxis in Children With Severe Haemophilia A: Egypt-Compare Study. [PDF]

Haemophilia
Hassan T, Elalfy M, Youssef MAM, Elalfy O, Elmasry E, Khalifa GL, Darwish A, Elhawary EE.   +7 more
europepmc   +1 more source